title: Recurrent bowel occlusion with oral ondansetron with no side effects of the intravenous route: a previously unknown adverse event.
authors.forename: C
authors.initials: C
authors.lastname: Lebrun
authors.forename: R M
authors.initials: RM
authors.lastname: Chichmanian
authors.forename: F
authors.initials: F
authors.lastname: Peyrade
authors.forename: M
authors.initials: M
authors.lastname: Chatel
authors.forename: M
authors.initials: M
authors.lastname: Frenay
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000932:Antiemetics / Q000009:adverse effects*; D006801:Humans; D007415:Intestinal Obstruction / Q000139:chemically induced*; D008297:Male; D017294:Ondansetron / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D012702:Serotonin Antagonists / Q000009:adverse effects*
chemical_list: D000932:Antiemetics; D012702:Serotonin Antagonists; D017294:Ondansetron